Molecular aspects of arrhythmias associated with cardiomyopathies

Current Opinion in Cardiology

Volumn 15, Issue 3, 2000, Pages 202-208

  Tomaselli, Gordon F ^a,c   Rose, Jochen ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CARRIER PROTEIN; POTASSIUM; SODIUM CALCIUM EXCHANGE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CALCIUM CELL LEVEL; CALCIUM CURRENT; CARDIOMYOPATHY; CAT; CHANNEL GATING; DOG; HEART ELECTROPHYSIOLOGY; HEART HYPERTROPHY; HEART MUSCLE POTENTIAL; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; HUMAN; MEMBRANE CURRENT; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; REVIEW; SODIUM CALCIUM EXCHANGE;

ACTION POTENTIALS; ARRHYTHMIA; CALCIUM CHANNELS; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; ELECTROPHYSIOLOGY; HEART CONDUCTION SYSTEM; HEART FAILURE, CONGESTIVE; HOMEOSTASIS; HUMANS; MOLECULAR BIOLOGY; RISK FACTORS; VENTRICULAR REMODELING;

EID: 0034030992     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200005000-00014     Document Type: Review

References (76)

1. 1 Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, et al.: Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986, 314:1547-1552.
2. 2 Wilson JR, Schwartz JS, Sutton MS, Ferraro N, Horowitz LN, Reichek N, Josephson ME: Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol 1983, 2:403-410.
3. 3 Potreau D, Gomez JP, Fares N: Depressed transient outward current in single hypertrophied cardiomyocytes isolated from the right ventricle of ferret heart. Cardiovasc Res 1995, 30:440-448.
4. + channel subunit mRNAs in ventricles of renovascular hypertensive rats. Circ Res 1997, 81:533-539.
5. 5 Thuringer D, Coulombe A, Deroubaix E, Coraboeuf E, Mercadier JJ: Depressed transient outward current density in ventricular myocytes from cardiomyopathic Syrian hamsters of different ages. J Mol Cell Cardiol 1996, 28:387-401.
6. + current in ventricular myocytes from acromegalic rats. Am J Physiol 1991, 260:H935-H942.
7. 7 Qin D, Zhang ZH, Caref EB, Boutjdir M, Jain P, el-Sherif N: Cellular and ionic basis of arrhythmias in postinfarction remodeled ventricular myocardium. Circ Res 1996, 79:461-473.
8. + channel genes in left ventricular remodeled myocardium after experimental myocardial infarction. Circ Res 1996, 79:669-675.
9. 9 Kääb S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, et al.: Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing induced heart failure. Circ Res 1996, 78:262-273.
10. 10 Rozanski GJ, Xu Z, Whitney RT, Murakami H, Zucker IH: Electrophysiology of rabbit ventricular myocytes following sustained rapid ventricular pacing. J Mol Cell Cardiol 1997, 29:721-732.
11. 2+ exchange. The alterations are similar to those reported in human heart failure.
12. 12 Gwathmey JK, Copellas L, MacKinnon R, Schoen RS, Feldman MD, Grossman W, Morgan JP; Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 1987, 61:70-76.
13. 13 Vermeulen JT, McGuire MA, Opthof T, Coronel R, de Bakker JM, Klopping C, Janse MJ: Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc Res 1994, 28:1547-1554.
14. 14 Beuckelmann DJ, Näbauer M, Erdmann E: Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circ Res 1992,85:1046-1055.
15. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 1993, 73:379-385.
16. 16 Pak PH, Nuss HB, Tunin RS, Kääb S, Tomaselli GF, Marban E, Kass DA: Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy. J Am Coll Cardiol 1997, 30:576-584.
17. 17 Drouin E, Charpentier F, Gauthier C, Laurent K, Le Marec H: Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells. J Am Coll Cardiol 1995, 26:185-192.
18. 18 Bryant SM, Shipsey SJ, Hart G: Regional differences in electrical and mechanical properties of myocytes from guinea-pig hearts with mild left ventricular hypertrophy. Cardiovasc Res 1997, 35:315-323.
19. 19 Barr CS, Naas A, Freeman M, Lang CC, Struthers AD: QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994, 343:327-329.
20. 20 Berger RD, Kasper EK, Baughman KL, Marban E, Calkins H, Tomaselli GF: Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997, 96:1557-1565.
21. 21 Näbauer M, Beuckelmann DJ, Uberfuhr P, Steinbeck G: Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation 1996, 93:168-177.
22. 22 Wettwer E, Amos GJ, Posival H, Ravens U: Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin. Circ Res 1994, 75:473-482.
23. Ca) density was reduced in hypertrophy, but the regional distribution was similar in the three regions studied in both control and hypertrophied hearts. These data may in part explain the reduction in the normal regional differences in action potential duration observed in hypertrophy.
24. 24 Näbauer M, Barth A, Kääb S: A second calcium-independent transient outward current present in human left ventricular myocardium [abstract]. Circulation 1998, 98:1-231.
25. 25 Po S, Snyders DJ, Baker R, Tamkun MM, Bennett PB: Functional expression of an inactivating potassium channel cloned from human heart. Circ Res 1992, 71:732-736.
26. 26 Kong W, Po S, Yamagishi T, Ashen MD, Stetten G, Tomaselli GF: Isolation and characterization of the human gene encoding the transient outward potassium current: further diversity by alternative mRNA splicing. Am J Physiol 1998, 275:H1963-H1970.
27. 27 Braun AP, Fedida D, Clark RB, Giles WR: Intracellular mechanisms for alpha 1 -adrenergic regulation of the transient outward current in rabbit atrial myocytes. J Physiol (Lond) 1990, 431:689-712.
28. 28 Kääb S, Dixon J, Duc J, Ashen MD, Näbauer M, Beuckelmann DJ, et al.: Molecular basis of transient outward current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation 1998, 98:1383-1393.
29. + current on the guinea pig action potential. Circ Res 1999, 84:964-972.
30. 30 Rose J, Winslow R, Jafri S, Marban E, Tomaselli GF: Role of Ito in determining action potential duration in rabbit ventricular myocytes [abstract]. Circulation 1998, 98:1-126.
31. 31 Kleiman RB, Houser SR: Outward currents in normal and hypertrophied feline ventricular myocytes. Am J Physiol 1989, 256:H1450-H1461.
32. 32 Ryder KO, Bryant SM, Hart G: Membrane current changes in left ventricular myocytes isolated from guinea pigs after abdominal aortic coarctation. Cardiovasc Res 1993, 27:1278-1287.
33. + channel in human cardiac myocytes. Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy. Circulation 1995, 92:164-174.
34. 34 Furukawa T, Myerburg RJ, Furukawa N, Kimura S, Bassett AL: Metabolic inhibition of ICa, L and IK differs in feline left ventricular hypertrophy. Am J Physiol 1994, 266:H1121-H1131.
35. K5 densities of both LV and RV cells were significantly lower in chronic AVB than control. Significant downregulation of delayed rectifier K current occurs in both ventricles of the dog with chronic AVB. Acquired TdP in this animal model with biventricular hypertrophy is related to intrinsic repolarization defects.
36. 36 Rose J, Zheng MQ, Juang G, Kong W, O'Rourke B, Marbán E, Tomaselli GF: Delayed rectifier current in heart failure: depressed function without resolvable changes in gene expression or protein level [abstract]. Circulation 1999, 100:1-425.
37. + current in human ventricular myocytes. Circ Res 1996, 78:689-696.
38. 38 Choy A-M, Kuperschmidt S, Lang CC, Pierson RN, Roden DM: Regional expression of HERG and KvLQT1 in heart failure. Circulation 1996, 94:164.
39. 39 Perez NG, Hashimoto K, McCune S, Altschuld RA, Marban E: Origin of contractile dysfunction in heart failure: calcium cycling versus myofilaments. Circulation 1999, 99:1077-1083.
40. 40 Hart G: Cellular electrophysiology in cardiac hypertrophy and failure. Cardiovas Res 1994, 28:933-946.
41. 41 Mewes T, Ravens U: L-type calcium currents of human myocytes from ventricle of non-failing and failing hearts and from atrium. J Mol Cell Cardiol 1994, 26:1307-1320.
42. 42 Ouadid H, Albat B, Nargeot J: Calcium currents in diseased human cardiac cells. J Cardiovasc Pharmacol 1995, 25:282-291.
43. 2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest 1992, 90:927-935.
44. 44 Schroeder F, Handrock R, Beuckelmann DJ, Hirt S, Hullin R, Priebe L, et al.: Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle. Circulation 1998, 98:969-976.
45. 2+ channels measured by nonlinear charge movement [abstract]. Circulation 1999, 100:1-191.
46. 2+]i handling in human ventricular myocytes from patients with terminal heart failure. Am Heart J 1995, 129:684-689.
47. 47 Brillantes AM, Allen P, Takahashi T, Izumo S, Marks AR: Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ Res 1992, 71:18-26.
48. 48 Go LO, Moschella MC, Watras J, Handa KK, Fyfe BS, Marks AR: Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest 1995, 95:888-894.
49. 49 Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, et al.: Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 1995, 92:778-784.
50. 2+ uptake by the SR in heart failure.
51. 51 Takeishi Y, Bhagwat A, Ball NA, Kirkpatrick DL, Periasamy M, Walsh RA: Effect of angiotensin-converting enzyme inhibition on protein kinase C and SR proteins in heart failure. Am J Physiol 1999, 276:H53-H62.
52. 2+ exchanger are differentially expressed across the left ventricular wall, implicating (1) different susceptibility of subendocardium and subepicardium to factors affecting expression of these proteins and (2) differences in regulation of the distinct calcium-cycling proteins.
53. 2+-uptake and SR PLB and SERCA protein and gene expression levels were reduced in LV myocardium of dogs with chronic HF.
54. 54 Hasenfuss G: Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res 1998, 37:279-289.
55. 55 Movsesian MA, Schwinger RH: Calcium sequestration by the sarcoplasmic reticulum in heart failure. Cardiovasc Res 1998, 37:352-359.
56. 2+-ATPase activity of cardiac sarcoplasmic reticulum for dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 1995, 92:3220-3228.
57. 2+-ATPase in failing and nonfailing human hearts. Cardiovasc Res 1996, 31:625-632.
58. 58 Hasenfuss G, Meyer M, Schillinger W, Preuss M, Pieske B, Just H: Calcium handling proteins in the failing human heart. Basic Res Cardiol 1997, 92:87-93.
59. 2+-ATPase activity and phosphorylation level of phospholamban. Am J Physiol 1999, 277:H474-H480.
60. 60 Minamisawa S, Hoshijima M, Chu G, Ward CA, Frank K, Gu Y, et al.: Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 1999, 99:313-322.
61. 2+-ATPase and phospholamban (PLB) in post-MI left ventricle of the rat compared with control. However, the basal levels of both the protein kinase A-phosphorylated site (Ser16) of PLB (p16-PLB) and the calcium/calmodulin-dependent protein kinase-phosphorylated site (Thr17) of PLB (p17-PLB) were decreased in post-MI myocytes. The prolonged relaxation of post-MI remodeled myocardium could be explained, in part, by altered basal levels of p16-PLB and p17-PLB caused by increased protein phosphatase 1 activity.
62. 2+ exchanger in failing human myocardium. Circulation 1996, 94:992-1002.
63. 2+ exchange activity in patients with end-stage heart failure. Cardiovasc Res 1996, 31:48-54.
64. 2+ homeostasis in rabbits with pacing-induced heart failure. Am J Physiol 1998, 275:H1441-H1448.
65. 2+-exchange (NCX) current density is unchanged in heart failure despite an increase in NCX protein [abstract]. Circulation 1998, 98:1-679.
66. 66 Ranjan R, Chiamvimonvat N, Thakor NV, Tomaselli GF, Marban E: Mechanism of anode break stimulation in the heart. Biophys J 1998, 74:1850-1863.
67. 67 Cerbai E, Pino R, Porciatti F, Sani G, Toscano M, Maccerini M, et al.: Characterization of the hyperpolarization-activated current, If, in ventricular myocytes from human failing heart. Circulation 1997, 95:568-571.
68. 68 Hoppe UC, Jansen E, Südkamp M, Beuckelmann DJ: Hyperpolarization-activated inward current in ventricular myocytes from normal and failing human hearts. Circulation 1998, 97:55-65.
69. +-ATPase in tachycardia induced cardiomyopathy. J Mol Cell Cardiol 1992, 24:277-294.
70. 70 Bristow MR: Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol 1993, 22:61A-71A.
71. 71 Hartzell HC, Duchatelle-Gourdon I: Regulation of the cardiac delayed rectifier K current by neurotransmitters and magnesium. Cardiovasc Drugs Ther 1993, 7 Suppl 3:547-554.
72. 72 Fedida D, Braun AP, Giles WR: Alpha 1-adrenoceptors in myocardium: functional aspects and transmembrane signaling mechanisms. Physiol Rev 1993, 73:469-487.
73. 73 Marban E. Molecular approaches to arrhythmogenesis. In: Chien K, ed. Molecular Basis of Heart Disease. New York: W.B. Saunders, 1998.
74. 74 Nuss HB, Kääb S, Kass DA, Tomaselli GF, Marban E: Increased susceptibility to arrhythmogenic early after depolarization and oscillatory prepotentials in failing canine ventricular myocytes. Circulation 1995, 92:434.
75. 75 Aronson RS, Ming Z: Cellular mechanisms of arrhythmias in hypertrophied and failing myocardium. Circulation 1993, 87:76-83.
76. 76 Sicouri S, Antzelevitch C: A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. Circ Res 1991, 68:1729-1741.